JU Open Plus

📢 Call for Papers: New Techniques in Urology JU Open Plus is looking for cutting-edge research and practical innovations that are transforming urologic care. ✨ 50% APC discount ✨ Rapid review process ✨ Open access reach ✨ Increased visibility through Special Issue promotion 📅 Deadline: October 23, 2026 Ready to share your work with a global audience? Click to learn more! tnyp.me/nstBih93/x

🩺 Can Surgery Techniques Reduce Prostate's Post-Op Complications? A study compares vesicourethral anastomotic stenosis (VUAS) outcomes after different robotic-assisted radical prostatectomy (#RARP) techniques. 🔬 No Stenosis - Retzius-sparing RARP showed zero cases of VUAS 📉 Lower Risk - This technique linked with lower odds of stenosis 📈 Risk Factors - Diabetes tripled VUAS risk #ProstateSurgery #Urology tnyp.me/YpSMVNcF/x

🔍 Is Confirmatory Biopsy in Prostate MRI Era Outdated? A study investigates if biopsy after multiparametric MRI (mp-MRI) is necessary in detecting prostate cancer among patients diagnosed with atypical small acinar proliferation (ASAP). 🔢 Significant Findings - mp-MRI PI-RADs ≥3 increases the likelihood of detecting significant cancer 🎯 Targeted Approach - mp-MRI and PSAD can stratify which patients may avoid unnecessary biopsies #ProstateCancer #MRI #Urology #ASAP #HealthcareResearch tnyp.me/iwS7lruB/x

🔬 Breakthroughs in Renal Cancer Treatment? New review highlights advanced therapies for clear-cell renal cell carcinoma (ccRCC). 💉 IO Revolution - IO-based strategies show enhanced survival in ccRCC 🔍 Biomarkers - Improved risk tools for tailored treatment ⚠️ Patient Safety - Need for irAE predictive biomarkers DOI: tnyp.me/75mGhIUA/x

🎯 Same Target, Different Tools: Revolutionizing Prostate Cancer Detection? A multicenter study compares 3 MRI-targeted transperineal biopsy techniques for detecting prostate cancer, impacting diagnosis accuracy. 🔬 Enhanced Detection - Local-anesthetic CF TPPB shows higher detection rates of csPCa than other methods 🏥 Practical Implications - Office-based biopsies under local anesthesia offer cost efficiency and convenience 🌐 International Insights - Study spans New Zealand, Australia, Switzerland, highlighting global techniques #ProstateCancer #Biopsy #HealthcareAdvancement #MRI tnyp.me/fxxExTcY/x

🔍 Real-World Evidence in Urethral Bulking Agents Henry et al. review reintervention rates for Bulkamid in women with stress urinary incontinence, contributing modest but vital U.S. data. 📉 Small Study - 56 women; no significant statistics 🔬 Data Limitations - Many had mixed incontinence 🌍 Diverse Insights - Adds U.S. real-world data #Incontinence #Bulkamid #SUI tnyp.me/LlX8P7Ub/x

🌏 Equitable Prostate Cancer Care: A Digital Approach? Research highlights how digital programs can bridge the survivorship care gap for prostate cancer patients in urban and rural areas. 📊 Equal Reach - High participant engagement across rural and urban settings 🏥 Mental Health Boost - Notable improvements in survivors' mental health 👍 High Satisfaction - 92% endorse digital care as standard #ProstateCancer #DigitalHealth #RuralHealth tnyp.me/XyOaDYk6/x

The June issue of JU Open Plus is here, featuring new research on prostate cancer detection, survivorship, robotic prostatectomy outcomes, and a systematic review of partial cystectomy—plus expert editorials and commentary. Check it out now! tnyp.me/dwSDEeEs/x

🔍 Can the PRIMARY Score Revolutionize Prostate Cancer Detection? This study evaluates the PRIMARY score's accuracy in identifying high-grade prostate cancer (ISUP ≥ 3). 🧪 High Sensitivity - PRIMARY score shows 94.4% sensitivity for ISUP ≥ 3 tumors 🔗 Complementary Tool - May enhance mpMRI for better hgPCa detection 📉 Low Specificity - Specificity stands at 22.2%, suggesting room for improvement #ProstateCancer #PRIMARYScore #PSMAPET tnyp.me/QySLnNKV/x

🩺 Heart Health Strategies in Prostate Cancer New trial investigates cardioprotective strategies for prostate cancer (PC) patients, aiming to cut heart disease risks associated with androgen deprivation therapy (ADT). 🧑‍⚕️ Specialist Referral - Routine cardiologist visits may lower cardiovascular risks 💊 Medication Impact - ADT linked with higher heart disease risk, to be further explored 📉 Lifestyle Changes - Smoking cessation, exercise, diet enhancements crucial for risk reduction tnyp.me/f0RldKpu/x

🔬 What's New in Renal Cancer Treatment? New review covers advanced therapies for clear-cell renal carcinoma, highlighting the shift from cytokines to targeted treatments and ICIs. 🧬 Combination Success - ICIs + VEGF inhibitors improve survival in metastatic cases 🔍 Biomarker Breakthroughs - AI, ctDNA, and spatial transcriptomics guide precision therapy 🎯 Emerging Targets - HIF-2α and TAM receptor antagonists show promise #RenalCancer #CancerResearch #ICIs #PrecisionMedicine tnyp.me/8hErYqlZ/x

🩺 Are We Optimizing Bladder Cancer Treatment? Research compares Gemcitabine Intravesical System (Gem-iDRS) with other novel agents for high-risk NMIBC after BCG relapse. 🧪 Innovative Approach - MAICs estimate treatment effectiveness across trials 📊 Potential Gains - Gem-iDRS may outperform pembrolizumab & nadofaragene ⚠️ Proceed Carefully - Head-to-head trials are needed for definitive conclusions tnyp.me/dTRfeFEl/x

🔬 Can Gemcitabine Transform Bladder Cancer Treatment? A study compares gemcitabine intravesical system (gem-iDRS) with novel therapies for BCG-unresponsive high-risk NMIBC. 📈 Better Outcomes - Gem-iDRS shows higher complete response rates, especially in CIS cohort 📉 Reduced Recurrence - Risk of progression or recurrence cut by 64% vs pembrolizumab 🔍 Need for Alternatives - Highlights need for bladder-preserving treatments 🔗 tnyp.me/VVMpDpPA/x

🌟 Meet Dr. Justin S. Han, New Editorial Board Member at JU Open Plus! Dr. Han, a urologist at Northwell Health, emphasizes tackling clinical grey areas with novel research and champions education's future in urology. 🧑‍⚕️ Clinical Focus - Male reconstructive urology, education leadership 📚 Research Insights - Novel studies should impact daily practice 🤝 Mentorship Value - Engage mentors for rigorous methodologies #Urology #MedicalResearch #Education tnyp.me/K6SlC8xD/x

🔍 Does Stapling the DVC in Robotic Prostatectomy Improve Outcomes? A pragmatic study finds suture ligation in robotic prostatectomy offers a cost-effective alternative to stapling without increasing positive margins. 📊 Similar Margins - No difference in positive surgical margins (30.8% vs. 30.2%) 💰 Cost Implications - Stapling adds ~$550 per case, reducing cost efficiency ⏳ Time Savings - Stapling saves time but doesn't alter oncologic results 👨‍⚕️ Surgeon Factors - Experience and technique may affect outcomes #Prostatectomy #Surgery #HealthcareEconomics tnyp.me/nexBarEH/x

📢 The May Issue of JUOP Is Here From insights shared at the 2026 EAU Congress to emerging treatment strategies across kidney, bladder, and prostate cancers, this issue explores how the field continues to evolve. Highlights include advances in systemic therapies for advanced renal cell carcinoma, new thinking around protecting cardiovascular health in prostate cancer care, and innovative approaches to managing high-risk bladder cancer when standard therapies fall short. Stay at the forefront of urologic oncology research and clinical innovation, click the link below to read the issue now! 🔗 bit.ly/4fw4MQr

Can artificial intelligence help close the gap in prostate cancer detection using microultrasound? In this article, the authors develop and evaluate a deep learning model to detect clinically significant prostate cancer and assess its impact on novice readers. They show that AI—especially when combined with training—can improve diagnostic performance and support more accurate clinical decision-making. 🔗 Click to read more: bit.ly/4drA4s1

Does surgical technique choice impact both cancer outcomes and cost in prostatectomy? In this article, the authors compare oversewing versus stapling of the dorsal venous complex during robotic prostatectomy, finding similar oncologic and postoperative outcomes between approaches. They also highlight a significant cost advantage with oversewing, offering important considerations for surgical decision-making. 🔗 Click to read more: bit.ly/3RnDp3L

What does it take to move beyond the limitations of traditional urinary diversion? In this comment, the author examines the balance between the proven benefits and significant complications of gut-based bladder reconstruction while exploring innovations like tissue engineering and transplantation. It also highlights the key challenges and ethical considerations shaping the future of bladder replacement. 🔗 Click to read more: bit.ly/4wwhFD6

What if bladder reconstruction didn’t have to rely on intestinal tissue and its complications? In this article, the authors review current urinary diversion techniques and emerging innovations like tissue engineering aimed at improving outcomes. They also outline key challenges that must be addressed to advance safer, more effective bladder replacement options. 🔗 Click to read more: bit.ly/4tuWmPm